Vivos Inc. (RDGL)
USD 0.12
(9.52%)
USD 0.12
(9.52%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 344.41 Thousand USD | -56.2% |
| 2019 | 786.38 Thousand USD | 1361.03% |
| 2018 | 53.82 Thousand USD | -98.17% |
| 2017 | 2.94 Million USD | 236.15% |
| 2016 | 876.7 Thousand USD | -71.43% |
| 2015 | 3.06 Million USD | -39.47% |
| 2014 | 5.07 Million USD | 390.2% |
| 2013 | 1.03 Million USD | -77.69% |
| 2012 | 4.63 Million USD | 29.05% |
| 2011 | 3.59 Million USD | 0.71% |
| 2010 | 3.56 Million USD | -0.48% |
| 2009 | 3.58 Million USD | 38.34% |
| 2008 | 2.59 Million USD | 265.17% |
| 2007 | 709.52 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | 0.0% |
| 2023 Q3 | 10 Thousand USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q4 | - USD | -100.0% |
| 2023 FY | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q1 | 294.86 Thousand USD | -14.39% |
| 2021 Q4 | - USD | -100.0% |
| 2021 Q3 | 295.76 Thousand USD | 0.15% |
| 2021 Q2 | 295.3 Thousand USD | 0.15% |
| 2020 Q3 | 293.96 Thousand USD | -25.3% |
| 2020 FY | 344.41 Thousand USD | -56.2% |
| 2020 Q1 | 508.06 Thousand USD | -35.39% |
| 2020 Q2 | 393.51 Thousand USD | -22.55% |
| 2020 Q4 | 344.41 Thousand USD | 17.16% |
| 2019 FY | 786.38 Thousand USD | 1361.03% |
| 2019 Q4 | 786.38 Thousand USD | 32.54% |
| 2019 Q3 | 593.3 Thousand USD | 82.12% |
| 2019 Q2 | 325.77 Thousand USD | 35.6% |
| 2019 Q1 | 240.25 Thousand USD | 346.36% |
| 2018 Q3 | 2.76 Million USD | -23.8% |
| 2018 Q2 | 3.62 Million USD | 1.13% |
| 2018 Q1 | 3.58 Million USD | 21.62% |
| 2018 FY | 53.82 Thousand USD | -98.17% |
| 2018 Q4 | 53.82 Thousand USD | -98.05% |
| 2017 Q1 | 1.45 Million USD | 65.96% |
| 2017 FY | 2.94 Million USD | 236.15% |
| 2017 Q4 | 2.94 Million USD | 25.78% |
| 2017 Q3 | 2.34 Million USD | 25.91% |
| 2017 Q2 | 1.86 Million USD | 27.9% |
| 2016 Q2 | 1.55 Million USD | -46.03% |
| 2016 Q3 | 1.73 Million USD | 11.51% |
| 2016 FY | 876.7 Thousand USD | -71.43% |
| 2016 Q1 | 2.88 Million USD | -6.07% |
| 2016 Q4 | 876.7 Thousand USD | -49.46% |
| 2015 Q2 | 5.84 Million USD | 7.35% |
| 2015 FY | 3.06 Million USD | -39.47% |
| 2015 Q4 | 3.06 Million USD | -10.16% |
| 2015 Q3 | 3.41 Million USD | -41.54% |
| 2015 Q1 | 5.44 Million USD | 7.36% |
| 2014 FY | 5.07 Million USD | 390.2% |
| 2014 Q1 | 5.26 Million USD | 409.33% |
| 2014 Q4 | 5.07 Million USD | 2.46% |
| 2014 Q3 | 4.94 Million USD | -1.36% |
| 2014 Q2 | 5.01 Million USD | -4.77% |
| 2013 Q1 | 873.27 Thousand USD | -81.16% |
| 2013 Q2 | 1.07 Million USD | 23.52% |
| 2013 Q3 | 1.07 Million USD | -0.2% |
| 2013 Q4 | 1.03 Million USD | -3.92% |
| 2013 FY | 1.03 Million USD | -77.69% |
| 2012 Q2 | 4.47 Million USD | 14.3% |
| 2012 FY | 4.63 Million USD | 29.05% |
| 2012 Q4 | 4.63 Million USD | 11.86% |
| 2012 Q3 | 4.14 Million USD | -7.48% |
| 2012 Q1 | 3.91 Million USD | 9.1% |
| 2011 Q3 | 3.28 Million USD | -0.41% |
| 2011 Q2 | 3.29 Million USD | 3.46% |
| 2011 FY | 3.59 Million USD | 0.71% |
| 2011 Q4 | 3.59 Million USD | 9.42% |
| 2011 Q1 | 3.18 Million USD | -10.68% |
| 2010 FY | 3.56 Million USD | -0.48% |
| 2010 Q4 | 3.56 Million USD | -20.71% |
| 2010 Q3 | 4.49 Million USD | 10.42% |
| 2010 Q2 | 4.07 Million USD | 4.5% |
| 2010 Q1 | 3.89 Million USD | 8.78% |
| 2009 Q1 | 2.74 Million USD | 6.12% |
| 2009 Q4 | 3.58 Million USD | 10.5% |
| 2009 Q3 | 3.24 Million USD | 6.07% |
| 2009 Q2 | 3.05 Million USD | 11.21% |
| 2009 FY | 3.58 Million USD | 38.34% |
| 2008 FY | 2.59 Million USD | 265.17% |
| 2008 Q4 | 2.59 Million USD | 0.0% |
| 2007 FY | 709.52 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| IR-Med Inc. | 161 Thousand USD | 100.0% |
| BioElectronics Corporation | 14.83 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 227 Thousand USD | 100.0% |
| CVR Medical Corp. | - USD | NaN% |
| Össur hf. | 467.73 Million USD | 100.0% |
| Polarean Imaging plc | 216.38 Thousand USD | 100.0% |
| Avitar, Inc. | 5.26 Million USD | 100.0% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 100.0% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | 100.0% |
| Zecotek Photonics Inc. | 3.22 Million USD | 100.0% |
| QHSLab, Inc. | 1.78 Million USD | 100.0% |
| Wellstar International, Inc. | 51.36 Million USD | 100.0% |
| Össur hf. | 467.73 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 100.0% |
| Escalon Medical Corp. | 524.71 Thousand USD | 100.0% |
| Aurora Spine Corporation | 2.67 Million USD | 100.0% |
| BrainsWay Ltd. | 471 Thousand USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | 3 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 100.0% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 100.0% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | 100.0% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | 100.0% |
| Nanomix Corporation | 11.4 Million USD | 100.0% |
| Theraclion SA | 1.95 Million EUR | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 4.04 Million USD | 100.0% |
| Positron Corporation | 1.78 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 1.69 Million USD | 100.0% |
| Lombard Medical, Inc. | 32.29 Million USD | 100.0% |
| ALR Technologies Inc. | 19.26 Million USD | 100.0% |
| Stratec SE | 156.16 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.11 Million USD | 100.0% |
| Heart Tronics, Inc. | 209.28 Thousand USD | 100.0% |
| Nu-Med Plus, Inc. | 100 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | 100.0% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 133.52 USD | 100.0% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 100.0% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | 2.14 Million USD | 100.0% |
| United American Healthcare Corporation | - USD | NaN% |
| ECGI Holdings, Inc. | 3.17 Million USD | 100.0% |
| Capital Group Holdings, Inc. | 4944.00 USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | 100.0% |
| Urologix, Inc. | 5.33 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 100.0% |
| SS Innovations International, Inc. | 8.21 Million USD | 100.0% |
| Qualis Innovations, Inc. | 9102.00 USD | 100.0% |
| Smith & Nephew plc | 3.07 Billion USD | 100.0% |
| NIOX Group Plc | 1.4 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.99 Million USD | 100.0% |
| Broncus Holding Corporation | 2.35 Million USD | 100.0% |
| Brain Scientific Inc. | 2.86 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 100.0% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | 100.0% |